We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
-6.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.96B
AUM Growth
-$641M
(-11%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
23.33%
Holding
765
New
46
Increased
242
Reduced
270
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manhattan Associates
MANH
|
+$33.6M |
| 2 |
Amazon
AMZN
|
+$32.3M |
| 3 |
CEB
CEB Inc.
CEB
|
+$27.7M |
| 4 |
Gilead Sciences
GILD
|
+$27.3M |
| 5 |
Merck
MRK
|
+$25.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$49.9M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$30.5M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
+$29.3M |
| 4 |
MIC
Macquarie Infrastructure Holdings, LLC
MIC
|
+$25M |
| 5 |
Sunoco
SUN
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.16% |
| 2 | Financials | 16.84% |
| 3 | Consumer Discretionary | 14.26% |
| 4 | Technology | 13.32% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
GE Aerospace
GE
$356B
| $7.69M | 0.16% |
63,654
+2,262
| +4% | +$277K |
|
|
FRC
102
DELISTED
First Republic Bank
FRC
| $6.97M | 0.14% |
111,123
+5,135
| +5% | +$321K |
|
103
ExxonMobil
XOM
$643B
| $6.88M | 0.14% |
92,514
-3,015
| -3% | -$232K |
|
104
Procter & Gamble
PG
$333B
| $6.79M | 0.14% |
94,345
-756
| -0.8% | -$56.7K |
|
105
State Street SPDR S&P 500 ETF Trust
SPY
$827B
| $6.68M | 0.13% |
34,857
+11,328
| +48% | +$2.3M |
|
106
Costco
COST
$415B
| $6.36M | 0.13% |
43,995
+4,940
| +13% | +$705K |
|
107
Intel
INTC
$487B
| $6.19M | 0.12% |
205,351
-3,578
| -2% | -$103K |
|
108
Pfizer
PFE
$160B
| $6.09M | 0.12% |
204,456
+2,200
| +1% | +$70.5K |
|
109
Euronet Worldwide
EEFT
$2.56B
| $5.51M | 0.11% |
74,420
-35,801
| -32% | -$2.4M |
|
|
HBI
110
DELISTED
Hanesbrands
HBI
| $5.24M | 0.11% |
181,006
+8,545
| +5% | +$265K |
|
111
PepsiCo
PEP
$191B
| $5.05M | 0.1% |
53,516
-431
| -0.8% | -$41K |
|
112
Vanguard FTSE Emerging Markets ETF
VWO
$127B
| $4.97M | 0.1% |
150,295
-6,652
| -4% | -$242K |
|
113
Baidu
BIDU
$32.9B
| $4.85M | 0.1% |
35,313
-1,907
| -5% | -$314K |
|
114
McDonald's
MCD
$184B
| $4.84M | 0.1% |
49,171
-318
| -0.6% | -$31K |
|
115
CME Group
CME
$101B
| $4.84M | 0.1% |
52,218
-49,998
| -49% | -$4.75M |
|
|
NORD
116
DELISTED
Nord Anglia Education, Inc.
NORD
| $4.75M | 0.1% |
233,420
+39,326
| +20% | +$906K |
|
117
Targa Resources
TRGP
$62B
| $4.69M | 0.09% |
91,092
-3,460
| -4% | -$253K |
|
118
Dollar General
DG
$27.8B
| $4.63M | 0.09% |
63,919
+3,171
| +5% | +$242K |
|
119
EOG Resources
EOG
$75.8B
| $4.6M | 0.09% |
63,203
+56,484
| +841% | +$4.39M |
|
120
RB Global
RBA
$15.9B
| $4.56M | 0.09% |
+176,027
| New | +$4.81M |
|
121
Oneok
OKE
$59.7B
| $4.52M | 0.09% |
140,477
-11,080
| -7% | -$405K |
|
122
Illinois Tool Works
ITW
$80.2B
| $4.35M | 0.09% |
52,903
-3,698
| -7% | -$323K |
|
123
Genesis Energy
GEL
$2B
| $4.18M | 0.08% |
109,155
-5,095
| -4% | -$220K |
|
124
iShares MSCI EAFE ETF
EFA
$79.8B
| $4.17M | 0.08% |
72,841
+4,344
| +6% | +$268K |
|
125
Alphabet (Google) Class C
GOOG
$4.13T
| $4.08M | 0.08% |
134,140
-424,620
| -76% | -$13M |
|
Similar funds
CAM
VKH
DL
RBC
TCM
HCM
AL
AT
Geneva Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, Geneva Advisors held 765 positions worth $4.96B, down 11% from $5.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geneva Advisors withdrew a net $193M in Q3 2015, closing 98 positions and reducing 270 holdings. Its most notable exit was Potash Corp Of Saskatchewan, an estimated $21.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Geneva Advisors opened a new position in Alphabet (Google) Class A worth $15.8M.
- Geneva Advisors's largest Q3 2015 buy was Alphabet (Google) Class A: 496,420 shares worth $15.8M.
- Geneva Advisors added most to Manhattan Associates in Q3 2015, an estimated $33.6M increase.
- Geneva Advisors's biggest Q3 2015 reduction was Biogen, cutting an estimated $49.9M.
- Geneva Advisors fully exited Potash Corp Of Saskatchewan in Q3 2015, selling an estimated $21.6M.
- Geneva Advisors's ten largest holdings make up 23% of its $4.96B portfolio in Q3 2015.
- Geneva Advisors opened 46 new positions and closed 98 in Q3 2015.
- Geneva Advisors's portfolio value fell 11% quarter-over-quarter to $4.96B.
Based on Geneva Advisors's 13F filing for Q3 2015, filed 3 Nov 2015.